These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38890214)

  • 21. The role of sulfides in stress-induced changes of Eh in Escherichia coli cultures.
    Tyulenev A; Smirnova G; Muzyka N; Ushakov V; Oktyabrsky O
    Bioelectrochemistry; 2018 Jun; 121():11-17. PubMed ID: 29316478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosomal mutations that accompany qnr in clinical isolates of Escherichia coli.
    Vinué L; Hooper DC; Jacoby GA
    Int J Antimicrob Agents; 2018 Mar; 51(3):479-483. PubMed ID: 29360506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
    Zhao X; Quinn B; Kerns R; Drlica K
    J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic-mediated recombination: ciprofloxacin stimulates SOS-independent recombination of divergent sequences in Escherichia coli.
    López E; Elez M; Matic I; Blázquez J
    Mol Microbiol; 2007 Apr; 64(1):83-93. PubMed ID: 17376074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QnrS1 structure-activity relationships.
    Tavío MM; Jacoby GA; Hooper DC
    J Antimicrob Chemother; 2014 Aug; 69(8):2102-9. PubMed ID: 24729602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of mutation at amino acid 45 of AcrR to acrB expression and ciprofloxacin resistance in clinical and veterinary Escherichia coli isolates.
    Webber MA; Talukder A; Piddock LJ
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4390-2. PubMed ID: 16189130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Cefotaxime- and Ciprofloxacin-Resistant Commensal Escherichia coli Originating from Belgian Farm Animals Indicates High Antibiotic Resistance Transfer Rates.
    Lambrecht E; Van Meervenne E; Boon N; Van de Wiele T; Wattiau P; Herman L; Heyndrickx M; Van Coillie E
    Microb Drug Resist; 2018; 24(6):707-717. PubMed ID: 29148895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depletion of reactive oxygen species induced by chlorogenic acid triggers apoptosis-like death in Escherichia coli.
    Lee B; Lee DG
    Free Radic Res; 2018 May; 52(5):605-615. PubMed ID: 29580121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo selection of an Escherichia coli isolate highly resistant to ciprofloxacin and ceftazidime: role of a 4-bp duplication in acrR and ampC overexpression.
    Corvec S; Lepelletier D; Reynaud A; Dauvergne S; Giraudeau C; Caroff N
    Int J Antimicrob Agents; 2008 Aug; 32(2):196-8. PubMed ID: 18571906
    [No Abstract]   [Full Text] [Related]  

  • 30. Ciprofloxacin-resistant and extended-spectrum β-lactamase-producing Escherichia coli ST410 strain carrying the mcr-1 gene associated with bloodstream infection.
    Rocha IV; Andrade CADN; Campos TL; Rezende AM; Leal NC; Vidal CFL; Xavier DE
    Int J Antimicrob Agents; 2017 May; 49(5):655-656. PubMed ID: 28302539
    [No Abstract]   [Full Text] [Related]  

  • 31. Mutant prevention concentrations of ciprofloxacin against urinary isolates of Escherichia coli and Klebsiella pneumoniae.
    Daoud Z; Sokhn ES; Azar E; Masri K; Doron S
    J Infect Dev Ctries; 2014 Feb; 8(2):154-9. PubMed ID: 24518624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of QnrA, a Plasmid-Mediated Quinolone Resistance Peptide, to Survival of Escherichia coli Exposed to a Lethal Ciprofloxacin Concentration.
    Goto K; Kawamura K; Arakawa Y
    Jpn J Infect Dis; 2015; 68(3):196-202. PubMed ID: 25672356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of drug transporter genes on cysteine export and overproduction in Escherichia coli.
    Yamada S; Awano N; Inubushi K; Maeda E; Nakamori S; Nishino K; Yamaguchi A; Takagi H
    Appl Environ Microbiol; 2006 Jul; 72(7):4735-42. PubMed ID: 16820466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.
    Olofsson SK; Marcusson LL; Komp Lindgren P; Hughes D; Cars O
    J Antimicrob Chemother; 2006 Jun; 57(6):1116-21. PubMed ID: 16624874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomewide screen for modulators of evolvability under toxic antibiotic exposure.
    Méhi O; Bogos B; Csörgo B; Pál C
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3453-6. PubMed ID: 23669383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of LsrR in the regulation of antibiotic sensitivity in avian pathogenic Escherichia coli.
    Yu L; Li W; Li Q; Chen X; Ni J; Shang F; Xue T
    Poult Sci; 2020 Jul; 99(7):3675-3687. PubMed ID: 32616264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6')-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro.
    Guillard T; Cambau E; Chau F; Massias L; de Champs C; Fantin B
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5830-5. PubMed ID: 24018262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ciprofloxacin provokes SOS-dependent changes in respiration and membrane potential and causes alterations in the redox status of Escherichia coli.
    Smirnova GV; Tyulenev AV; Muzyka NG; Peters MA; Oktyabrsky ON
    Res Microbiol; 2017 Jan; 168(1):64-73. PubMed ID: 27498196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of the contribution of active defense mechanisms to ciprofloxacin tolerance in Escherichia coli growing at different rates.
    Smirnova GV; Tyulenev AV; Muzyka NG; Oktyabrsky ON
    Antonie Van Leeuwenhoek; 2022 Feb; 115(2):233-251. PubMed ID: 35022927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward repurposing ciclopirox as an antibiotic against drug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae.
    Carlson-Banning KM; Chou A; Liu Z; Hamill RJ; Song Y; Zechiedrich L
    PLoS One; 2013; 8(7):e69646. PubMed ID: 23936064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.